A lot of researchers have reported about the imbalance of cytokines in patients with melanoma - statistically low levels of IL-2 and IFN-γ and high levels of IL-4, IL-6 and IL-10 that reflects the imbalance between Th1/Th2 immune responses [35]. This evidence concerns the gene IL2 and melanoma.